Episode notes
Dantrolene: The Only Drug That Stops Malignant Hyperthermia at Its Source
You shut off the volatile, pour on the cooling, chase the acidosis and the soaring potassium — and a jammed calcium channel deep in the muscle keeps emptying its stores into the cell anyway. In malignant hyperthermia, everything you do buys time. One drug reaches the leak itself.
Dantrolene binds the ryanodine receptor and shuts it — the only intervention that ends the crisis rather than managing it, and the reason a supply sits in every place on earth that delivers anesthesia.
The full episode, available on Supercast, goes underneath: why the gate fails to reseal in the first place, why no amount of cooling from outside can close it, how the dosing matches the danger, and why a molecule that does exactly one thing can reverse a catastrophe the whole body is feeding.
Key Takeaways
- In malignant hyperthermia, every intervention except one buys time rather than ending the crisis.
- Dantrolene binds the ryanodine receptor and stabilizes its closed state — the only drug that reaches the cause.
- The defect lives in the muscle's own calcium store. External cooling and buffering cannot reach it.
- No other drug in the crisis touches the cause. That's why a supply sits in every place that delivers anesthesia.
- Malignant Hyperthermia Hotline
- North America: 1-800-644-9737 (1-800-MH-HYPER)
- Outside of North America: 001-209-417-3722
Provides 24/7 by the Malignant Hyperthermia Association of the United States (MHAUS).
Timestamps
00:00 — The fire you can't put out from outside
00:45 — The one drug that reaches the leak
01:35 — What the full episode answers
FULL EPISODE
The complete Dantrolene episode — the failed gate, the mechanism, dosing, and selectivity — is on Supercast:
https://diaryofaloststudent.supercast.com/
If this made something click, leave a 5-star rating and follow the show. That's how other anesthesia providers — residents, SRNAs, SAAs, CRNAs, and anesthesiologists — find it. New episodes twice a week.